Furthermore, according to a Kaplan–Meier survival analysis, patients with DLBCL who exhibit high levels of PPP4C had worse overall survival (P = 0.001) and progression-free survival (P = 0.002). The gene discussed is PPP4C; the disease is diffuse large B-cell lymphoma.